Novo Nordisk A/S Common Stock (NVO) Total Costs & Expenses & History | Stock Alarm

Demo Sign up Log In

Novo Nordisk A/S Common Stock · Total Costs & Expenses

NVO Total Costs & Expenses

Latest reportedkr 187.33B DKKperiod endingJun 30, 2026

NVO Total Costs & Expenses · DKK (kr 3.43B → kr 187.33B)

Annual Total Costs & Expenses

High-resolution chart · PNG

NVO total costs & expenses history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Total Costs & Expenses — Annual fiscal periods (DKK)
Period ending	Total Costs & Expenses (DKK)
Dec 31, 2025	181,406,000,000
Dec 31, 2024	162,064,000,000
Dec 31, 2023	129,687,000,000
Dec 31, 2022	102,145,000,000
Dec 31, 2021	82,156,000,000
Dec 31, 2020	72,820,000,000
Dec 31, 2019	69,538,000,000
Dec 31, 2018	64,583,000,000
Dec 31, 2017	62,729,000,000
Dec 31, 2016	63,348,000,000
Dec 31, 2015	58,483,000,000
Dec 31, 2014	54,314,000,000
Dec 31, 2013	52,079,000,000
Dec 31, 2012	48,552,000,000
Dec 31, 2011	43,972,000,000
Dec 31, 2010	41,885,000,000
Dec 31, 2009	36,145,000,000
Dec 31, 2008	33,261,326,000
Dec 31, 2007	32,934,160,000
Dec 31, 2006	29,631,746,000
Dec 31, 2005	25,638,287,000
Dec 31, 2004	22,203,679,000
Dec 31, 2003	20,209,609,000
Dec 31, 2002	19,180,540,000
Dec 31, 2001	18,119,848,000
Dec 31, 2000	16,571,799,000
Dec 31, 1999	13,521,815,000
Dec 31, 1998	12,215,780,000
Dec 31, 1997	14,649,884,000
Dec 31, 1996	12,923,895,000
Dec 31, 1995	11,840,483,000
Dec 31, 1994	11,677,760,000
Dec 31, 1993	11,201,558,000
Dec 31, 1992	9,512,246,000
Dec 31, 1991	8,425,554,800
Dec 31, 1990	7,279,492,800
Dec 31, 1989	6,569,176,500
Dec 31, 1988	4,693,567,200
Dec 31, 1987	4,380,335,250
Dec 31, 1986	3,518,526,000
Dec 31, 1985	3,425,144,400

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.